Apr. 1 at 8:38 AM
$ARCT Arcturus Therapeutics, Inc. v. AbbVie Inc. et al., Case No. 3:25-cv-02494
March 30, 2026: The court issued an order on the motion to dismiss (docket entry 27), signed by Judge Huie. Public docket summaries and monitoring services do not include the full text of the order or explicitly state whether the motion was granted, denied, or granted/denied in part. No further docket entries (e.g., answers, discovery orders, or scheduling) are reflected in available public sources as of early April 2026.
As of Arcturus’ most recent public disclosure in its Q4 2025 earnings release (March 3, 2026), the company described the lawsuit as “remains ongoing.” No press releases, SEC filings, or news reports indicate a dismissal, settlement, or other resolution. Given the recency of the March 30 order (issued two days before the current date of April 1, 2026), detailed analysis or immediate public commentary is not yet available.
